October 31, 2025

Scar Management After Dermatologic Surgery

Hydrocolloid dressing may help patients avoid daily wound care.

Conexiant

October 06, 2025

Can Nicotinamide Reduce the Risk of Skin Cancer Development?

A retrospective study aimed to determine the clinical efficacy of nicotinamide supplementation for skin cancer prevention in the general population and among solid organ transplant recipients.

The ASCO Post

January 23, 2025

Getting a Lung Cancer Diagnosis Was Shocking

Dr. Ho, a non-smoking Asian American physician, shares her journey of being diagnosed with lung cancer, her successful treatment, and her advocacy work to raise awareness about the risk of lung cancer in never smokers.

The ASCO Post

February 24, 2023

Updated Results From the ADAURA Trial: Continued Disease-Free Survival Benefit With Adjuvant Osimertinib vs Placebo in EGFR-Mutated Stage IB–IIIA NSCLC

As reported in the Journal of Clinical Oncology by Roy S. Herbst, MD, PhD, of Yale Cancer Center and Yale School of Medicine, and colleagues, updated findings in the phase III ADAURA trial showed cont...

The ASCO Post

August 08, 2024

EGFR- and ALK-Altered NSCLC: TKIs With Stereotactic Radiosurgery for Brain Metastases

The addition of upfront stereotactic radiosurgery to CNS-penetrant TKI treatment prolonged time to CNS progression vs TKI treatment alone in TKI-naive patients with brain metastases from EGFR- and ALK...

The ASCO Post

April 09, 2024

RP1 Immunotherapy in Solid Organ Transplant Recipients With Skin Cancer

Researchers evaluated a novel oncolytic immunotherapy in solid organ transplant recipients with skin cancer. They presented their findings at the AACR Annual Meeting 2024.

The ASCO Post

November 27, 2023

Iruplinalkib Demonstrates Improved Efficacy and Tolerance vs Crizotinib in ALK Inhibitor–Naive, Advanced ALK-Positive NSCLC

The novel ALK tyrosine kinase inhibitor iruplinalkib has demonstrated potential for a difficult-to-treat subset of patients with non–small cell lung cancer (NSCLC), according to data presented at the...

The ASCO Post

October 17, 2022

Combining expertise with innovation - Multimodality skin cancer treatment at Lynn Cancer Institute

The World Health Organization reports that non­melanoma and melanoma skin cancers have been increasing over the last decade, highlighting the importance of early detection and treatment.

Baptist Health South Florida

October 09, 2024

Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I NSCLC

The Canadian phase III LUSTRE trial, reported in JAMA Oncology by Swaminath et al, evaluated local tumor control for stereotactic body radiotherapy vs hypofractionated conventional radiotherapy in pat...

The ASCO Post